BG105460A - Prv-1 gene and the use thereof - Google Patents

Prv-1 gene and the use thereof

Info

Publication number
BG105460A
BG105460A BG105460A BG10546001A BG105460A BG 105460 A BG105460 A BG 105460A BG 105460 A BG105460 A BG 105460A BG 10546001 A BG10546001 A BG 10546001A BG 105460 A BG105460 A BG 105460A
Authority
BG
Bulgaria
Prior art keywords
gene
prv
essentially
detecting
well
Prior art date
Application number
BG105460A
Other languages
Bulgarian (bg)
English (en)
Inventor
Heike Pahl
Original Assignee
Universitatsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatsklinikum Freiburg filed Critical Universitatsklinikum Freiburg
Publication of BG105460A publication Critical patent/BG105460A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BG105460A 1998-10-23 2001-04-20 Prv-1 gene and the use thereof BG105460A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19849044A DE19849044A1 (de) 1998-10-23 1998-10-23 Das Gen PRV-1 und dessen Verwendung
PCT/EP1999/007238 WO2000024886A1 (fr) 1998-10-23 1999-09-30 Le gene prv-1 et son utilisation

Publications (1)

Publication Number Publication Date
BG105460A true BG105460A (en) 2002-06-28

Family

ID=7885492

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105460A BG105460A (en) 1998-10-23 2001-04-20 Prv-1 gene and the use thereof

Country Status (28)

Country Link
US (2) US6686153B1 (fr)
EP (1) EP1123392B1 (fr)
JP (1) JP2002528077A (fr)
KR (1) KR20010080883A (fr)
CN (1) CN1190491C (fr)
AT (1) ATE348109T1 (fr)
AU (1) AU771772B2 (fr)
BG (1) BG105460A (fr)
BR (1) BR9915537A (fr)
CA (1) CA2349211A1 (fr)
CZ (1) CZ20011430A3 (fr)
DE (2) DE19849044A1 (fr)
EA (1) EA200100440A1 (fr)
EE (1) EE200100234A (fr)
HR (1) HRP20010294A2 (fr)
HU (1) HUP0104954A3 (fr)
IL (1) IL142664A0 (fr)
LT (1) LT4877B (fr)
LV (1) LV12722B (fr)
MX (1) MXPA01004035A (fr)
NO (1) NO20011961L (fr)
NZ (1) NZ510970A (fr)
PL (1) PL347413A1 (fr)
SI (1) SI20585A (fr)
SK (1) SK5402001A3 (fr)
WO (1) WO2000024886A1 (fr)
YU (1) YU29801A (fr)
ZA (1) ZA200103210B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1141285A2 (fr) * 1998-12-16 2001-10-10 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
DE19947010A1 (de) * 1999-09-30 2001-04-05 Universitaetsklinikum Freiburg Das Gen PRV-1 und dessen Verwendung
JP2010540534A (ja) * 2007-09-28 2010-12-24 イントレキソン コーポレーション 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0991757A1 (fr) * 1997-05-06 2000-04-12 ZymoGenetics Nouveaux antigenes tumoraux

Also Published As

Publication number Publication date
MXPA01004035A (es) 2003-03-10
WO2000024886A1 (fr) 2000-05-04
LT4877B (lt) 2002-01-25
LT2001055A (en) 2001-10-25
JP2002528077A (ja) 2002-09-03
LV12722B (en) 2002-01-20
KR20010080883A (ko) 2001-08-25
DE19849044A1 (de) 2000-04-27
EP1123392A1 (fr) 2001-08-16
NO20011961D0 (no) 2001-04-20
HUP0104954A2 (hu) 2002-04-29
CA2349211A1 (fr) 2000-05-04
YU29801A (sh) 2005-07-19
US6686153B1 (en) 2004-02-03
SK5402001A3 (en) 2001-09-11
US20040259110A1 (en) 2004-12-23
PL347413A1 (en) 2002-04-08
NZ510970A (en) 2003-06-30
AU6088399A (en) 2000-05-15
DE59914061D1 (de) 2007-01-25
EA200100440A1 (ru) 2001-10-22
CZ20011430A3 (cs) 2001-08-15
CN1324403A (zh) 2001-11-28
HRP20010294A2 (en) 2002-06-30
ATE348109T1 (de) 2007-01-15
EP1123392B1 (fr) 2006-12-13
IL142664A0 (en) 2002-03-10
NO20011961L (no) 2001-06-21
CN1190491C (zh) 2005-02-23
ZA200103210B (en) 2002-08-14
AU771772B2 (en) 2004-04-01
HUP0104954A3 (en) 2004-07-28
LV12722A (lv) 2001-09-20
BR9915537A (pt) 2001-11-13
EE200100234A (et) 2002-08-15
SI20585A (sl) 2001-12-31

Similar Documents

Publication Publication Date Title
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
ZA200006039B (en) Novel nucleotide sequences coding for the poxB gene.
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
AR015687A2 (es) Gen aislado que codifica acil transferasa
EP1037999A4 (fr) Polypeptides et nucleotides porphyromonas gingivalis
EP0811684A3 (fr) Fragments et variants du récepteur de l'oxytocine, et ADN correspondants
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
EP0643719A4 (fr) Sequences d'acides nucleique codant pour des sequences d'acides nucleiques qui codent pour le recepteur de l'interleukine-9, ou complementaires a ces sequences.
BG105460A (en) Prv-1 gene and the use thereof
GB9416536D0 (en) Orphan receptor
EP1010761A4 (fr) Gene
ATE412751T1 (de) Menschliche tak1 und für diese kodierende dna
PE20399A1 (es) Muteina ob
ATE202798T1 (de) D-aminosäure-oxidase kodierendes dns-fragment
ATE318933T1 (de) Nukleinsäurefragmente zur identifizierung von dechlorierenden bakterien
WO2002083727A3 (fr) Sequences d'acides nucleiques relatives a des hyperplasies et tumeurs de la glande thyroide
EP1013665A4 (fr) Nouveau polypeptide deployant une activite de circulation de l'eau et sequence d'adn
TW342413B (en) Novel toxins isolated from Bracon Hebetor
ZA200007078B (en) New nucleotide sequences coding for the glk-gene.
EP0945512A3 (fr) Sérine protéases
WO2000006731A3 (fr) La persephine arf, proteine codee par un arnm de persephine sans epissure
SI1794294T1 (sl) Rekombinantna karboksipeptidaza B
EP1251172A4 (fr) Proteine wtip interagissant avec wt1
EP0636694A3 (fr) Thymopoietine humaine et composé apparanté, procédé de production et séquences de DNA recombinants.